These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 10534517

  • 1. Effect of mycophenolate mofetil on erythropoiesis in stable renal transplant patients is correlated with mycophenolic acid trough levels.
    van Besouw NM, van der Mast BJ, Smak Gregoor PJ, Hesse CJ, IJzermans JN, van Gelder T, Weimar W.
    Nephrol Dial Transplant; 1999 Nov; 14(11):2710-3. PubMed ID: 10534517
    [Abstract] [Full Text] [Related]

  • 2. Randomized study on the conversion of treatment with cyclosporine to azathioprine or mycophenolate mofetil followed by dose reduction.
    Smak Gregoor PJ, van Gelder T, van Besouw NM, van der Mast BJ, IJzermans JN, Weimar W.
    Transplantation; 2000 Jul 15; 70(1):143-8. PubMed ID: 10919591
    [Abstract] [Full Text] [Related]

  • 3. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO, Ehlermann P, Koch A, Remppis A, Katus HA, Dengler TJ.
    Clin Ther; 2006 Jun 15; 28(6):893-905. PubMed ID: 16860172
    [Abstract] [Full Text] [Related]

  • 4. Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findings.
    Zucker K, Rosen A, Tsaroucha A, de Faria L, Roth D, Ciancio G, Esquenazi V, Burke G, Tzakis A, Miller J.
    Transpl Immunol; 1997 Sep 15; 5(3):225-32. PubMed ID: 9402690
    [Abstract] [Full Text] [Related]

  • 5. Effect of cyclosporine on mycophenolic acid trough levels in kidney transplant recipients.
    Gregoor PJ, de Sévaux RG, Hené RJ, Hesse CJ, Hilbrands LB, Vos P, van Gelder T, Hoitsma AJ, Weimar W.
    Transplantation; 1999 Nov 27; 68(10):1603-6. PubMed ID: 10589962
    [Abstract] [Full Text] [Related]

  • 6. Effects of azathioprine and mycophenolate mofetil-immunosuppressive regimens on the erythropoietic system of renal transplant recipients.
    Khosroshahi HT, Asghari A, Estakhr R, Baiaz B, Ardalan MR, Shoja MM.
    Transplant Proc; 2006 Sep 27; 38(7):2077-9. PubMed ID: 16980004
    [Abstract] [Full Text] [Related]

  • 7. Mycophenolic acid plasma concentrations in kidney allograft recipients with or without cyclosporin: a cross-sectional study.
    Smak Gregoor PJ, van Gelder T, Hesse CJ, van der Mast BJ, van Besouw NM, Weimar W.
    Nephrol Dial Transplant; 1999 Mar 27; 14(3):706-8. PubMed ID: 10193823
    [Abstract] [Full Text] [Related]

  • 8. Trough levels of mycophenolic acid and its glucuronidated metabolite in renal transplant recipients.
    Merkel U, Lindner S, Vollandt R, Sperschneider H, Balogh A.
    Int J Clin Pharmacol Ther; 2005 Aug 27; 43(8):379-88. PubMed ID: 16119513
    [Abstract] [Full Text] [Related]

  • 9. Mycophenolic acid trough levels after kidney transplantation in a cyclosporine-free protocol.
    Smak Gregoor PJ, van Gelder T, van Besouw NM, van der Mast BJ, Hesse CJ, IJzermans JN, Weimar W.
    Transpl Int; 2000 Aug 27; 13 Suppl 1():S333-5. PubMed ID: 11112026
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics help optimizing mycophenolate mofetil dosing in kidney transplant patients.
    Cattaneo D, Gaspari F, Ferrari S, Stucchi N, Del Priore L, Perico N, Gotti E, Remuzzi G.
    Clin Transplant; 2001 Dec 27; 15(6):402-9. PubMed ID: 11737117
    [Abstract] [Full Text] [Related]

  • 11. Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant.
    Pawinski T, Durlik M, Szlaska I, Urbanowicz A, Majchrnak J, Gralak B.
    J Clin Pharm Ther; 2006 Feb 27; 31(1):27-34. PubMed ID: 16476117
    [Abstract] [Full Text] [Related]

  • 12. Reversal of chronic cyclosporine nephrotoxicity after heart transplantation-potential role of mycophenolate mofetil.
    Tedoriya T, Keogh AM, Kusano K, Savdie E, Hayward C, Spratt PM, Wilson M, Macdonald PS.
    J Heart Lung Transplant; 2002 Sep 27; 21(9):976-82. PubMed ID: 12231368
    [Abstract] [Full Text] [Related]

  • 13. Cyclosporin withdrawal with concomitant conversion from azathioprine to mycophenolate mofetil in renal transplant recipients with chronic allograft nephropathy: a 2-year follow-up.
    Ducloux D, Motte G, Billerey C, Bresson-Vautrin C, Vautrin P, Rebibou JM, Saint-Hillier Y, Chalopin JM.
    Transpl Int; 2002 Sep 27; 15(8):387-92. PubMed ID: 12221456
    [Abstract] [Full Text] [Related]

  • 14. Improvement of impaired renal function in heart transplant recipients treated with mycophenolate mofetil and low-dose cyclosporine.
    Aleksic I, Baryalei M, Busch T, Pieske B, Schorn B, Strauch J, Sîrbu H, Dalichau H.
    Transplantation; 2000 Apr 27; 69(8):1586-90. PubMed ID: 10836367
    [Abstract] [Full Text] [Related]

  • 15. Conversion to mycophenolate mofetil in conjunction with stepwise withdrawal of cyclosporine in stable renal transplant recipients.
    Schrama YC, Joles JA, van Tol A, Boer P, Koomans HA, Hené RJ.
    Transplantation; 2000 Feb 15; 69(3):376-83. PubMed ID: 10706046
    [Abstract] [Full Text] [Related]

  • 16. Renal graft function and low-dose cyclosporine affect mycophenolic acid pharmacokinetics in kidney transplantation.
    Cortinovis M, Gotti E, Pradini S, Gaspari F, Perico N.
    Transplantation; 2011 Sep 15; 92(5):550-6. PubMed ID: 21709602
    [Abstract] [Full Text] [Related]

  • 17. Mycophenolic acid pharmacokinetics in pediatric liver transplant recipients.
    Aw MM, Brown NW, Itsuka T, Gonde CE, Adams JE, Heaton ND, Tredger JM, Mieli-Vergani G, Dhawan A.
    Liver Transpl; 2003 Apr 15; 9(4):383-8. PubMed ID: 12682891
    [Abstract] [Full Text] [Related]

  • 18. Reduced kidney transplant rejection rate and pharmacoeconomic advantage of mycophenolate mofetil.
    Wüthrich RP, Weinreich T, Ambühl PM, Schwarzkopf AK, Candinas D, Binswanger U.
    Nephrol Dial Transplant; 1999 Feb 15; 14(2):394-9. PubMed ID: 10069195
    [Abstract] [Full Text] [Related]

  • 19. Renal function and safety of heart transplant recipients switched to mycophenolate mofetil and low-dose cyclosporine.
    Baryalei M, Zenker D, Pieske B, Tondo K, Dalichau H, Aleksic I.
    Transplant Proc; 2003 Jun 15; 35(4):1539-42. PubMed ID: 12826215
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of mycophenolic acid in kidney transplant patients receiving sirolimus versus cyclosporine.
    El Haggan W, Ficheux M, Debruyne D, Rognant N, Lobbedez T, Allard C, Coquerel A, Ryckelynck JP, Hurault de Ligny B.
    Transplant Proc; 2005 Mar 15; 37(2):864-6. PubMed ID: 15848558
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.